Peripheral blood stem cell autotransplantation in treatment of childhood cancer

Bone Marrow Transplant. 1989 May;4(3):261-5.

Abstract

The levels of circulating hematopoietic progenitor cells were measured sequentially in eight children receiving chemotherapy for acute leukemia or neuroblastoma. Significant increases in the progenitor levels (up to 50-fold in CFU-GM numbers) were observed during post-chemotherapy cytopenia in all cases, but differences among individuals in the kinetics of recovery of less committed progenitors (CFU-mix) contrasted with the synchronized-mode of expansion of committed progenitors (CFU-GM). Peripheral blood cells were collected by repeated continuous-flow leukaphereses from three of the children during post-chemotherapy expansion of the progenitor pool and were cryopreserved after fractionation procedures. Infusion of these stored cells into the patients after marrow-ablative chemotherapy established trilineage hematopoiesis. This use of stem cell rescue should be useful as an alternative to bone marrow transplantation and extends the application of cure-oriented salvage therapy to childhood cancers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Cell Count
  • Child
  • Child, Preschool
  • Colony-Forming Units Assay
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Infant
  • Kinetics
  • Leukemia, Myeloid, Acute / blood
  • Leukemia, Myeloid, Acute / therapy
  • Lymphoma, Non-Hodgkin / blood
  • Lymphoma, Non-Hodgkin / therapy
  • Neoplasms / blood
  • Neoplasms / therapy*
  • Neuroblastoma / blood
  • Neuroblastoma / therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / blood
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy
  • Transplantation, Autologous